Hmf Intensive (shelf-stable) (25 Capsules)

No reviews

Exclusive Human-Strain Probiotic for Extra Daily Support • Provides 25 Billion CFU Per Capsule • Probiotics to help supplement normal intestinal microbiota after antibiotic therapy • Helps improve symptoms of Irritable Bowel Syndrome (IBS) such as bloating, satisfaction with bowel habits and pain days within 6 weeks • No refrigeration necessary • Potency guaranteed through expiration HMF® Intensive provides a combination of human-strain, clinically proven probiotics to help supplement normal intestinal microbiota after antibiotic therapy and significantly reduce symptoms of Irritable Bowel Syndrome (IBS) in adults and children over 11 years of age. While the composition of the gut microflora is relatively stable, it can be altered by diet, stress, age and the use of medications.1 Clinical trials have demonstrated that supplementation with HMF® Intensive probiotic formula promoted gastrointestinal health and helped reduce the degree of microflora disruption associated with antibiotic intake.2,3 Supplementation with 25 billion CFU of Lactobacillus acidophilus (CUL-60 and CUL-21), Bifidobacterium bifidum (CUL-20), and Bifidobacterium animalis subsp. lactis (CUL-34) has also been associated with a lower incidence and severity of gastrointestinal symptoms in marathon runners.4 In addition, a clinical trial reported that daily supplementation with this probiotic formula for eight weeks significantly improved six measures of IBS symptoms (symptom severity score, abdominal pain, bloating, pain days, satisfaction with bowel habits, and quality of life).5 HMF® Intensive contributes to a healthy, natural gut flora with a concentrated dose of 25 billion CFU per capsule. This convenient, shelf-stable format has guaranteed potency through expiration and can improve patient compliance. References REFERENCES 1. Nagpal R, Yadav H, Kumar M, Jain S. Probiotics and Prebiotics in Diet, Nutrition and Health. Boca Raton, FL: CRC Press, 2013. p.1-24. 2. Madden JA, Plummer SF, Tang J, Garaiova I, Plummer NT, Herbison M, et al. Int Immunopharmacol. 2005 Jun;5(6):1091-7. 3. Plummer SF, Garaiova I, Sarvotham T, Cottrell SL, Le Scouiller S, Weaver MA, et al. Int J Antimicrob Agents. 2005 Jul;26(1):69-74. 4. Pugh JN, Sparks SA, Doran DA, Fleming SC, Langan-Evans C, Kirk B, Fearn R, et al. Eur J Appl Physiol. 2019 Jul;119(7):1491-1501. 5. Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, et al. Aliment Pharmacol Ther. 2009 Jan;29(1):97-103.